entertainment -WSS

entertainment

author：Wikipedia 2025-10-01 18:43:57 - browse：7536

Sanofi, the Paris-based drug giant, announced Friday that it would spin out its $5 billion consumer health division, which is exploring over-the-counter moves for the erectile dysfunction drug Cialis and the flu treatment Tamiflu.

Investors reacted swiftly, bidding Sanofi’s American depository receipts on the New York Stock Exchange down nearly 18% to less than $44 in morning trading. Jared Holz, an analyst at Mizuho, warned investors that the drop “would be the largest negative single-day stock move across Global Pharma in more than ten years.”

It would be tempting to take the stock move as evidence that investors have finally tired of watching drug companies treat consumer product divisions like baseball trading cards, buying them at a high price only to sell them again a decade later. But the move probably has little to do with the current passion for pharma spinouts or with Sanofi following in the footsteps of GSK, Novartis, and Pfizer in shedding a division. Or even, for that matter, Sanofi, which shed its pharmaceutical ingredients business, EuroAPI, which is now trading at a third of its initial public offering price.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Do masks work? RCTs can't tell us

entertainment

WSS

Male and female sex labels in research insufficient, scientists say

Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

John Green on his newest strategy for fighting tuberculosis

HHS secretary Becerra pressed on Change HealthCare cyberattack

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

How to save health care price transparency rules

entertainment

entertainment

entertainment

Tori Bowie and the unacceptable rates of Black maternal death

HHS secretary Becerra pressed on Change HealthCare cyberattack

Cancer drug shortages should be causing more outrage

How to save health care price transparency rules

Affirmative action in medical school literally saved lives

Obesity experts on risks of Wegovy, Ozempic weight loss drugs

The high cost of giving birth even with insurance

Cloning humans is technically possible. It's curious no one has tried

Cancer drug shortages should be causing more outrage

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

entertainment

#NeedHerScience: shining a light on gender disparities in medicine

Change Healthcare outage fallout shows need for new oversight

Change Healthcare outage fallout shows need for new oversight

UCLA team creates talking throat patch for voice disorders

The science behind Janet Jackson's pregnancy at 49

Why depression after traumatic brain injury is distinct

leisure time

entertainment

focus

focus